Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013), A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Rese, Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer and the tags subtype-page, lung.
Shares Lobectomy, PET/CT, PD-1 / PD-L1 immune checkpoint & T-cell activation, MRI and the tags subtype-page, lung.
Shares A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC), ALK-positive non-small-cell lung cancer, Pemetrexed, Roche / Genentech and the tags subtype-page, lung.
Shares Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutati, John V. Heymach, ALK-positive non-small-cell lung cancer, Pemetrexed and the tags subtype-page, lung.
Shares PD-L1-high non-small-cell lung cancer without a driver mutation, Pemetrexed, EGFR-mutated non-small-cell lung cancer, PD-L1 and the tags subtype-page, lung.
Shares PET/CT, PD-1 / PD-L1 immune checkpoint & T-cell activation, MRI, Atezolizumab and the tags subtype-page, lung.
Shares Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV), ALK-positive non-small-cell lung cancer, Pemetrexed, Roche / Genentech and the tags subtype-page, lung.
Shares Adenocarcinoma of the lung, ALK-positive non-small-cell lung cancer, Osimertinib, Pemetrexed and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.